News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
LIfT BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the World Leader in Neutrophil Immunotherapies
Friday, March 14, 2025LIfT BioSciences a rapidly emerging biotech and the global leader in neutrophil immunotherapies has been granted another pivotal patent further reinforcing its leadership in innate immunebased cell therapies and in vivo immune modulation
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
Thursday, March 13, 2025Atsena Therapeutics a clinicalstage gene therapy company focused on using the lifechanging power of genetic medicine to reverse or prevent blindness today announced that the US Food and Drug Administration FDA has granted Fast Track designation for A...
ATyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
Thursday, March 13, 2025ATyr Pharma Inc a clinical stage biotechnology company engaged in the discovery and development of firstinclass medicines from its proprietary tRNA synthetase platform today announced a publication demonstrating the mechanism of action for its lead t...
Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate
Wednesday, March 12, 2025Vaxart Inc announced the initiation of a Phase open label dose ranging clinical trial evaluating its secondgeneration oral norovirus vaccine constructs headtohead against its firstgeneration constructs We are pleased to initiate a Phase trial for o...
Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera
Wednesday, March 12, 2025Ono Pharmaceutical Co Ltd announced that it has entered into a license agreement with Ionis Pharmaceuticals Inc for sapablursen an investigational RNAtargeted medicine for the treatment of polycythemia vera PV Sapablursen is currently being evaluated...
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
Tuesday, March 11, 2025OKYO Pharma Limited a clinicalstage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain a severe ocular condition without an FDA approved therapy and for inflammatory dry eye disease a multibilliond...
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Tuesday, March 11, 2025Polyrizon Ltd a development stage biotech company specializing in the development of innovative intranasal hydrogels announced today the initiation of preclinical studies for intranasal Naloxone a lifesaving opioid overdose treatment
Lundbeck’s potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan
Monday, March 10, 2025The Ministry of Health Labor and Welfare MHLW in Japan has granted Orphan Drug Designation ODD to Lundbecks investigational drug amlenetug a potential new treatment option targeting Multiple System Atrophy MSA
Orion and Aiforia extend collaboration to preclinical study evaluations
Thursday, March 06, 2025Orion Corporation and Aiforia Technologies Plc a Finnish medical software company today announced the extension of their collaboration to include the use of Aiforias software solution for preclinical study evaluations This collaboration will involve...
Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe
Thursday, March 06, 2025Bioxodes SA a clinical stage biopharmaceutical company developing novel therapies for the prevention and treatment of thrombotic and inflammatory diseases has received Orphan Drug Designation ODD for its firstinclass BIOX therapeutic candidate to tre...
